GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Net Income Including Noncontrolling Interests

Samsung BioLogics Co (XKRX:207940) Net Income Including Noncontrolling Interests : ₩895,298 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Samsung BioLogics Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ₩179,362 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ₩895,298 Mil.

Samsung BioLogics Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Samsung BioLogics Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Net Income Including Noncontrolling Interests Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202,904.10 240,974.80 393,589.47 798,056.21 857,691.30

Samsung BioLogics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141,755.37 184,885.68 240,366.71 290,683.54 179,361.79

Samsung BioLogics Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩895,298 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Samsung BioLogics Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co (XKRX:207940) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XKRX:068270 XKRX:326030 XKRX:302440 XKRX:028300 XKRX:196170 XKRX:145020 XKRX:048410 XKRX:086900 XKRX:214450 XKRX:141080 OCSE:NOVO B VRTX REGN ASX:CSL SGEN MRNA HKSE:02269 XBRU:ARGX BNTX BGNE
Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Website
https://www.samsungbiologics.com
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines